Evidence from a recent study, led by MSK urologic surgeon, Behfar Ehdaie, MD, MPH, indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active ...
Background: Active surveillance is considered a mainstream strategy in the management of patients with low-risk prostate cancer. A mission-critical step in implementing a robust active ...
Because prostate cancer cells usually grow very slowly, some men might not need treatment right away. Your doctor might suggest something called active surveillance. That means instead of having ...
However, although a PSA velocity greater than 2.0 identified 100% of patients dying of prostate cancer within 10 years of surgery in the D'Amico group, cause-specific survival at 10 years in this ...
New research provides scientific evidence that a healthy diet may reduce the chance of low risk prostate cancer progressing to a more aggressive state in men undergoing active surveillance -- a ...
Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the ...